Munar Pharma

Munar Pharma Equity

Delisted

The The Equity of Munar Pharma (MUN.WA) as of Nov 20, 2026 is -1.06 M PLN. In the previous year, The Equity was -1.34 M PLN — a change of -20.95% (higher).

Equity

-1.06 MPLN

YoY

-20.95%

Last updated:

In 2024, Munar Pharma's equity was -1.06 M PLN, a -20.95% increase from the -1.34 M PLN equity in the previous year.

The Munar Pharma Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2017
14.94 M PLN
Jan 1, 2018
2.27 M PLN
Jan 1, 2019
1.65 M PLN
Jan 1, 2020
1.22 M PLN
Jan 1, 2021
2.44 M PLN
Jan 1, 2022
2.25 M PLN
Jan 1, 2023
-1.34 M PLN
Jan 1, 2024
-1.06 M PLN
The Munar Pharma Equity history
YEAREquityYoY
-1.06 MPLN-20.95%
-1.34 MPLN-159.50%
2.25 MPLN-7.68%
2.44 MPLN+100.53%
1.22 MPLN-26.26%
1.65 MPLN-27.19%
2.27 MPLN-84.84%
14.94 MPLN+2,287.36%
625,900.00PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Munar Pharma Stock analysis

What does Munar Pharma do? No Gravity Games SA generates revenue by providing internet-related services, including content management systems, web shops, and website implementation. The company leverages its own technical infrastructure and programming resources to create and maintain specialized websites for its corporate clients. These digital assets include audiostereo.pl for audio enthusiasts, zagraj.com.pl as an online games portal, and legalneinfo.pl, which serves as an online catalogue of free software. The firm further supports application development and external software development for its corporate clients. Its portfolio extends to sport1.pl, offering information on disciplines such as football, volleyball, basketball, tennis, handball, and winter sports. Additional sites managed by the company include YOYO.pl, an independent provider of free hosting services, as well as chillisport.pl, oboe.pl, legenhit.pl, webtips.pl, xt.pl, and websonda.pl. Munar Pharma is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Munar Pharma's Equity

Munar Pharma's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Munar Pharma's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Munar Pharma's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Munar Pharma's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Munar Pharma’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Munar Pharma stock

The Equity of Munar Pharma is -1.06 M PLN in 2024.

The Equity of Munar Pharma changed from -1.34 M PLN to -1.06 M PLN, representing a -20.95% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Munar Pharma since 2006 – with annual values, charts, and detailed analysis.

The Equity's PLN is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Munar Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Munar Pharma

All Key Metrics — Munar Pharma